# Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia

> **NCT03248063** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 315 (actual)

## Conditions studied

- Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus

## Interventions

- **DRUG:** Cloxacillin
- **DRUG:** Cefazolin

## Key facts

- **NCT ID:** NCT03248063
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-05
- **Primary completion:** 2024-02-22
- **Final completion:** 2025-03-10
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03248063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03248063, "Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03248063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*